Protega

Apr 22, 2025

Protega Pharmaceuticals joins forces in an exclusive agreement with OPOS Solutions software technology platform to improve patient education and chronic pain care

Mar 03, 2025

Protega Pharmaceuticals collaborates with Wellgistics Health to support pharmacist education and increase patient access to the first and only FDA-approved abuse-deterrent immediate-release opioid, ROXYBOND(TM)

Oct 29, 2024

Protega Pharmaceuticals Receives FDA Approval for ROXYBOND(TM) (oxycodone hydrochloride) Immediate-Release 10 mg Tablet with Abuse-Deterrent Technology for Management of Pain